Table 2. Correlation between RPS15A expression and clinicopathological factors in 75 lung adenocarcinoma patients specimens.
Variables | All patients | RPS15A expression | P* | |
---|---|---|---|---|
Negative | Positive | |||
Total | 75 | 26 | 49 | |
Age(y) | ||||
≤60 | 48 | 14 | 25 | 1.000 |
>60 | 27 | 12 | 24 | |
Gender | ||||
Male | 43 | 19 | 24 | 0.053 |
Female | 32 | 7 | 25 | |
TNM stage | ||||
I∼II | 47 | 20 | 36 | 0.788 |
III∼IV | 28 | 6 | 13 | |
Tumor size | ||||
≤3 cm | 8 | 1 | 7 | 0.249 |
>3 cm | 67 | 25 | 42 | |
Lymph node metastasis | ||||
Yes | 28 | 8 | 20 | 0.458 |
No | 47 | 18 | 29 |
Note:
P values were obtained with the χ2 test.